Search alternatives:
point decrease » point increase (Expand Search)
ng decrease » nn decrease (Expand Search), _ decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a point » _ point (Expand Search), 5 point (Expand Search), _ points (Expand Search)
5 ng » 5 mg (Expand Search), 5 g (Expand Search), 5 nm (Expand Search)
Showing 41 - 60 results of 69,414 for search '(( a point decrease ) OR ((( 5 ng decrease ) OR ( 5 ((ng decrease) OR (a decrease)) ))))', query time: 0.89s Refine Results
  1. 41
    Secondary efficacy endpoints for the modified intent-to-treat population.

    Secondary efficacy endpoints for the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  2. 42
    Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population.

    Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  3. 43
    Source data for Fig 1.

    Source data for Fig 1. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  4. 44
    Diarrheal stool output rate overall and by blood type status in the modified intent-to-treat population.

    Diarrheal stool output rate overall and by blood type status in the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  5. 45
    Source data for S1 and S2 Figs.

    Source data for S1 and S2 Figs. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  6. 46
    Source data for Fig 2.

    Source data for Fig 2. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  7. 47
    Consolidated Standards for Reporting of Trials flow diagram.

    Consolidated Standards for Reporting of Trials flow diagram. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  8. 48
    iOWH032 inhibits cholera toxin-induced fecal output in a cecectomized rat model.

    iOWH032 inhibits cholera toxin-induced fecal output in a cecectomized rat model. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  9. 49
    Source data for Fig 3.

    Source data for Fig 3. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  10. 50
    Scatterplot of iOWH032 plasma concentrations versus diarrheal stool output rate.

    Scatterplot of iOWH032 plasma concentrations versus diarrheal stool output rate. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  11. 51
    Reverse cumulative distribution plot for diarrheal stool output rate overall in the modified intent-to-treat population.

    Reverse cumulative distribution plot for diarrheal stool output rate overall in the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  12. 52
    Diarrheal disease severity by treatment group for the modified intent-to-treat population.

    Diarrheal disease severity by treatment group for the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  13. 53
    Reference mutations versus background noise across replicates.

    Reference mutations versus background noise across replicates. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 54
    Quantification and accuracy of average VAF.

    Quantification and accuracy of average VAF. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 55
    Analytical sensitivity and reproducibility.

    Analytical sensitivity and reproducibility. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  16. 56
    Depth of coverage and heterogeneity of the mutation loci. x-axis, mutation loci in sample set one or two; y-axis, depth of coverage after UMI consolidation.

    Depth of coverage and heterogeneity of the mutation loci. x-axis, mutation loci in sample set one or two; y-axis, depth of coverage after UMI consolidation. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  17. 57
    Impact of mutation type on VAF quantification performance.

    Impact of mutation type on VAF quantification performance. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  18. 58
    Schematic overview of the cross-platform study.

    Schematic overview of the cross-platform study. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  19. 59
    Impact of DNA extraction process on depth of coverage.

    Impact of DNA extraction process on depth of coverage. by Lizhi Yu (12476136)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  20. 60
    TBEV-induced translational arrest results in the decreased protein levels of GAPDH, HPRT1, and viperin.

    TBEV-induced translational arrest results in the decreased protein levels of GAPDH, HPRT1, and viperin. by Martin Selinger (3195987)

    Published 2019
    Save to List
    Saved in:

Search Tools: